Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kobayashi Pharmaceutical Co OCF Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Kobayashi Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kobayashi Pharmaceutical Co (FRA:KOY) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Kobayashi Pharmaceutical Co and its competitors. Over the past decade, Kobayashi Pharmaceutical Co's OCF Margin % has ranged from 6.79 to 19.20. According to the industry distribution chart, Kobayashi Pharmaceutical Co ranks #365 out of 1959 companies in the Consumer Packaged Goods industry, placing it in the top 18.6%.
Is Kobayashi Pharmaceutical Co's OCF Margin % too high?
Kobayashi Pharmaceutical Co's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 6.79 to a high of 19.20. Based on the distribution chart, Kobayashi Pharmaceutical Co ranks #365 out of 1959 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's OCF Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kobayashi Pharmaceutical Co ranks #365 out of 1959 companies for OCF Margin %. This places Kobayashi Pharmaceutical Co in the top 19% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 6.54. Historically, Kobayashi Pharmaceutical Co's own OCF Margin % has ranged from 6.79 to 19.20 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Consumer Packaged Goods company?
The median OCF Margin % among Consumer Packaged Goods companies is 6.54, based on 1,959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Kobayashi Pharmaceutical Co and its competitors. For the Consumer Packaged Goods industry, the median OCF Margin % is 6.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kobayashi Pharmaceutical Co's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Kobayashi Pharmaceutical Co (FRA:KOY) has a current OCF Margin % of 0.00%. The stock's GF Value™ is €30.01, compared to a current price of €28.40 — trading 5.4% below its estimated fair value. The current OCF Margin % is 0.00%. Kobayashi Pharmaceutical Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (FRA:KOY), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kobayashi Pharmaceutical Co (FRA:KOY) Overvalued in 2026?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be undervalued.
The current stock price of €28.40 is trading 5.4% below its estimated GF Value™ of €30.01.
Key valuation signals for FRA:KOY:
OCF Margin %: 0.00%
GF Value™: €30.01 vs. price of €28.40 (5.4% below fair value)
No single metric tells the full story. See the FRA:KOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
81GF Score
Get the complete analysis for FRA:KOY
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:KOY has been successfully added to your 
